GE HealthCare delivers first PET MPI agent doses for CAD detection
GE HealthCare has delivered the initial subject doses of Flyrcado (flurpiridaz F 18) injection, for coronary artery disease (CAD) detection. The post GE HealthCare delivers first PET MPI agent doses for CAD detection appeared first on Medical Device Network.

The post GE HealthCare delivers first PET MPI agent doses for CAD detection appeared first on Medical Device Network.